Shengda Lin1,2,3, Elisabete M Nascimento1,2,3, Chandresh R Gajera1,2,3, Lu Chen1,2,3, Patrick Neuhöfer1,2,3, Alina Garbuzov1,2,3, Sui Wang4, Steven E Artandi5,6,7. 1. Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. 2. Department of Biochemistry, Stanford University School of Medicine, Stanford, CA, USA. 3. Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. 4. Department of Ophthalmology, Stanford University School of Medicine, Stanford, CA, USA. 5. Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. sartandi@stanford.edu. 6. Department of Biochemistry, Stanford University School of Medicine, Stanford, CA, USA. sartandi@stanford.edu. 7. Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. sartandi@stanford.edu.
Abstract
Hepatocytes are replenished gradually during homeostasis and robustly after liver injury1, 2. In adults, new hepatocytes originate from the existing hepatocyte pool3-8, but the cellular source of renewing hepatocytes remains unclear. Telomerase is expressed in many stem cell populations, and mutations in telomerase pathway genes have been linked to liver diseases9-11. Here we identify a subset of hepatocytes that expresses high levels of telomerase and show that this hepatocyte subset repopulates the liver during homeostasis and injury. Using lineage tracing from the telomerase reverse transcriptase (Tert) locus in mice, we demonstrate that rare hepatocytes with high telomerase expression (TERTHigh hepatocytes) are distributed throughout the liver lobule. During homeostasis, these cells regenerate hepatocytes in all lobular zones, and both self-renew and differentiate to yield expanding hepatocyte clones that eventually dominate the liver. In response to injury, the repopulating activity of TERTHigh hepatocytes is accelerated and their progeny cross zonal boundaries. RNA sequencing shows that metabolic genes are downregulated in TERTHigh hepatocytes, indicating that metabolic activity and repopulating activity may be segregated within the hepatocyte lineage. Genetic ablation of TERTHigh hepatocytes combined with chemical injury causes a marked increase in stellate cell activation and fibrosis. These results provide support for a 'distributed model' of hepatocyte renewal in which a subset of hepatocytes dispersed throughout the lobule clonally expands to maintain liver mass.
Hepatocytes are replenished gradually during homeostasis and robustly after liver injury1, 2. In adults, new hepatocytes originate from the existing hepatocyte pool3-8, but the cellular source of renewing hepatocytes remains unclear. Telomerase is expressed in many stem cell populations, and mutations in telomerase pathway genes have been linked to liver diseases9-11. Here we identify a subset of hepatocytes that expresses high levels of telomerase and show that this hepatocyte subset repopulates the liver during homeostasis and injury. Using lineage tracing from the telomerase reverse transcriptase (Tert) locus in mice, we demonstrate that rare hepatocytes with high telomerase expression (TERTHigh hepatocytes) are distributed throughout the liver lobule. During homeostasis, these cells regenerate hepatocytes in all lobular zones, and both self-renew and differentiate to yield expanding hepatocyte clones that eventually dominate the liver. In response to injury, the repopulating activity of TERTHigh hepatocytes is accelerated and their progeny cross zonal boundaries. RNA sequencing shows that metabolic genes are downregulated in TERTHigh hepatocytes, indicating that metabolic activity and repopulating activity may be segregated within the hepatocyte lineage. Genetic ablation of TERTHigh hepatocytes combined with chemical injury causes a marked increase in stellate cell activation and fibrosis. These results provide support for a 'distributed model' of hepatocyte renewal in which a subset of hepatocytes dispersed throughout the lobule clonally expands to maintain liver mass.
He patocytes execute metabolic activities of the liver and exhibit functional
heterogeneity along the axis within the lobule defined from the portal vein to the
central vein[12]. At the extreme ends of
this axis, pericentral Axin2+ hepatocytes repopulated the liver
during normal homeostasis[13], whereas
periportal hepatocytes marked by Sox9 expression were inactive during homeostasis, but
expanded with chronic chemical damage[14]. Observations indicating that proliferating hepatocytes are located
throughout the lobule[15,16] suggest additional sources of repopulating
hepatocytes. Telomerase synthesizes telomere repeats, and has been linked to long-term
renewal in stem cells and in cancers[17]. Germline inactivating mutations in telomerase genes predispose to
cirrhosis in people[9,10] and in mice[11], while activating mutations in the TERT
promoter represent the most recurrent mutations in hepatocellular carcinoma[18]. Given the important roles of
telomerase in liver disease, and observations that telomerase is found in stem cell
compartments in multiple adult tissues[19-22], we hypothesized that
telomerase may be expressed in liver cells with unique properties.To reveal telomerase-expressing cells in vivo, we engineered a
mouse strain expressing the inducible CreERT2 recombinase from the endogenous
Tert locus (Extended Data Fig.
1a-d). Treatment of Tert
knock-in mouse ES cells in culture with 4-hydroxy tamoxifen resulted in efficient
recombination of a fluorescent reporter (Extended Data
Fig.1e-g). To study the adult liver, we
intercrossedTert mice and a
Rosa26 reporter strain that
enables permanent cell labelling by deletion of a transcriptional stop element flanked
by loxP sites and concomitant expression of fluorescent Tomato protein.
Tertmice were injected with a
near-saturating dose of tamoxifen (1mg/10g body weight)(Extended Data Fig.1i), and analyzed three days later (Fig. 1a). We found that a subset of cells throughout the liver
expressed Tomato and the hepatocyte marker HNF4A (Fig.
1b). Tomato expression in other liver cell types was not detected (Extended Data Fig. 1k-n). To isolate these
TERTHigh hepatocytes by fluorescence-activated cell sorting (FACS)
(Gating strategy, Supplementary
Information), we labeled all hepatocytes with an adeno-associated virus
expressing hepatocyte-specific GFP (AAV.GFP)[23] (Figure 1c and Extended Data Fig. 1h). We found that all
Tomato+ cells were also GFP+, typically
representing 3-5% of all hepatocytes from 2-month old mice (Fig. 1d). Telomeric repeat amplification protocol (TRAP)
showed a 5-fold increase of telomerase activity in the TERTHigh population
(GFP+Tomato+) compared with the
TERTLow population (GFP+Tomato-) (Fig. 1e and Extended
Data Fig. 1j; gel source, Supplementary Figure 1). Quantitative reverse transcription PCR showed
12.9-fold more Tert mRNA in the TERTHigh population than in
the bulk TERTLow hepatocyte population (Fig.
1f, g). Both populations were comprised of a similar distribution of diploid
and polyploid cells (Extended Data Fig. 2). These
data show that Tert mRNA and telomerase activity are elevated in
TERTHigh hepatocytes.
Extended Data Figure 1
Generation and characterization of the
Tert knock-in
line
a-d, Tert targeting
strategy and southern-blot strategy (a). Southern-blots using a
5′probe (b), a NeoR probe (c), and a
3′probe (d). KI, knock-in cells. WT, wild-type cells.
For gel source data, see Supplementary Figure 1. e-g,
Tert
mouse embryonic stem cells showed either membrane Tomato (f,
overlaid on bright-field image), or membrane EGFP(g, overlaid
on bright-field image) in response to 500nM 4-hydroxy tamoxifen (4-HT).
h, hepatocytes from
Tert;
Rosa26 livers before
and after FACS-enrichment. i, Tamoxifen dose response of
Tert livers (n = 3
mice for each group, cross-bar: mean). j, Quantification of the
TRAP assay shown in Fig.1e by
densitometry. k-n, Co-immunofluorescence for Tomato (red) and
CD45 (k, blood cells, 202 cells examined), CD68
(l, Kupffer cells, 179 cells examined), GFAP (m,
stellate cells, 158 cells examined) and PECAM (n, endothelial,
167 cells examined) (each in green) in
Tert;
Rosa26 liver, 3-day
trace, with DAPI (blue). Experiments repeated twice for b-d,
f-g, k-n. Scale bars, 100 μm in
g,h, 50 μm in k-n.
Figure 1
Identification of a hepatocyte subpopulation with elevated
Tert and telomerase activity
a-b, Immunofluorescence (IF) analysis on
Tert;
Rosa26 liverstreated
with single-dose of tamoxifen and analysed 3 days post injection. Tomato (red),
HNF4A (green), CK19 (white), and DAPI (blue) shown. c-g, Analysis
of telomerase expression in FACS-sorted hepatocytes. Representative FACS plot
(d), TRAP assay (e, B: Buffer only) and
quantitative reverse-transcription PCR(f, position of primer pairs)
(g, fold-changes.n = 3 mice, each indicated by unique
dot shapes; cross-bar: mean) shown. Experiments repeated three times for
b, more than five times for d, and twice for
e and g. Scale bars, 50 μm.
Extended Data Figure 2
Ploidy and nuclear profiles of the TERTLow and
TERTHigh lineages
a-c, Ploidy analysis by Hoechst incorporation and FACS
in TERTLow (a) and TERTHigh
(b) hepatocytes. Quantification showed no significant
differences between TERTLow and TERTHighcells
regarding ploidies (c, n = 5 mice, each represented by
unique dot-shapes). d-f, Nuclei count by Tomato(red),
phalloidin(green) and DAPI(blue) in livers traced by 3 days (d)
and 6 months (e). Quantification showed no significant
differences between TERTLow and TERTHighcells in
binuclei fractions (f, n = 4 mice for each group, each
represented by unique dot-shapes). Experiments repeated twice. Scale bar, 50
μm.
To determine whether TERTHigh hepatocytes repopulate the liver during
homeostasis, we performed lineage tracing by injecting two-month old
Tertmice with a single dose of tamoxifen
(1 mg/10 g) and aged these animals for up to one year (Fig. 2a). TERTHigh hepatocytes represented
2.8±0.4% three days after tamoxifen, but the Tomato+
progeny of these cells increased progressively during the tracing period to comprise
29.9±2.4% of liver area at one year (Fig.
2b-h). All Tomato+ cells remained
HNF4A+ hepatocytes after tracing for one-year (Extended Data Fig. 3a-e) and Tomato+ cells
were undetected in mice treated with oil vehicle (Fig.
2i). A single tamoxifen injection generated a similar number of
Tomato+ hepatocytes as three injections administered at 5-week
intervals over the same tracing period (Extended Data Fig.
3f-i), indicating that elevated Tert promoter activity is an
intrinsic feature of cell identity. Co-staining sections from this lineage tracing time
course series for Tomato and the pericentral zone marker glutamine synthetase
(GS)[12] showed that
TERTHigh hepatocytes were distributed throughout all lobular zones. The
vast majority of TERTHigh hepatocytes were located in the periportal and
midlobular zones (3-day trace), and the progeny from these cells expanded markedly to
replenish hepatocytes in these zones. Within the pericentralzone, the
TERTHigh lineage comprised 1.8±0.3% at three days (Fig. 2j), but increased overtime
(8.2±0.5% at 6 months, and 12.7±0.9% at 1 year, Fig. 2k-m and Extended
Data Fig.4). Analysis of proliferating hepatocyte position by Ki-67
immunostaining revealed that Ki-67+ hepatocytes were dispersed
throughout all lobular zones in both wild-type and
Tertmice, matching the distributed
pattern of TERTHigh hepatocytes (Extended Data
Fig. 5a, b, h). These data show that rare TERTHigh hepatocytes
drive a marked and progressive repopulation of the hepatocyte lineage throughout the
lobule during normal homeostasis.
Figure 2
TERTHigh hepatocytes repopulate the liver in homeostasis and show
downregulation of metabolic genes
a-i, Lineage tracing in
Tert;
Rosa26 micetreated with
single-dose tamoxifen (b-g) or oil vehicle (i) and
analysed at indicated tracing periods by IF for Tomato. Quantification of
Tomato+hepatocyte area (h, n = 4, 5,
4, 4, 7, 5 mice for each time-point;cross-bar: mean). j-m, Co-IF
for Tomato and GS inTert;
Rosa26 micetraced for 3
days, 6 months or one year.Quantification of
Tomato+GS+ fraction of
GS+ hepatocytes (m, n = 4, 5, 5 mice
for each time-point; cross-bars, mean). n-o, RNA-seq results on
FACS-purified TERTHigh (Tomato+) or
TERTLow (Tomato-) hepatocytes (n = 3 mice for
each group). Volcano plot for enriched genes and GO terms
(n,cut-offs:q< 0.05,
|log2(fold difference)|> 0.8). GSEA
analysis for enriched gene-sets (o, number of genes shown for each
gene set). Experiments repeated twice for time-points in
b,f,g,j-l. Scale bars,
100 μm.
Extended Data Figure 3
Characterization of the lineage expansion of TERTHigh
hepatocytes
a-e, IF performed on
Tert;
Rosa26 livers after
one-year trace showed TERTHigh hepatocytes exclusively gave rise
to hepatocytes. f-i, Repeated injections showed
TERTHigh cells as a constant proportion of the liver. Lineage
expansion over one injection (g) and three injections
(h) was quantified (i, n = 3 mice for
each group; cross-bar: mean). j, Heat map showing
differentially regulated genes among all TERTLow and
TERTHigh samples. Class I and Class 2 refer to genes
significantly down-regulated and up-regulated in TERTHigh
samples, respectively. Genes assigned to DAVID- generated annotation
clusters shown on the right. Experiments repeated twice. Scale bar, 200
μm.
Extended Data Figure 4
Zonal pattern of TERTHigh lineage hepatocytes
a-d, Stitched images of IF for Tomato protein (red) and
GS (green) in liver sections from Tert mice treated with
tamoxifen and traced for three days (a), three months
(b), six months (c) or one year
(d). e-g, FACS-isolated and
cytospunhepatocytes from Tert mice treated with
tamoxifen and traced for three days were stained for CPS1 (red) and GS
(green) in TERTLow (e) and TERTHigh
hepatocytes (f), and quantified for the GS+
fraction of all cells (g, n = 3 mice; cross-bars:
mean). Experiments repeated three times. Scale bars, 200 μm.
Extended Data Figure 5
Distribution of proliferating hepatocytes in
Tert and
Tert livers in
homeostasis and under injury hepatocytes
a-f, Livers were stained with anti-Ki-67 antibody with
standard immunohistochemistry. Ki-67+ nuclei were
indicated by brown colours in uninjured livers (a,
b), and CCl4 (10 μL/10 g weight) injured
livers (c, d), with haematoxylin counterstain in
light blue. Green chromogen was used to indicate Ki-67+
nuclei in DDC (0.1%) treated livers (e,
f). Hepatocyte nuclei were distinguished by size and
morphology. Examples of Ki-67+ hepatocytes nuclei were
shown in box insets. g, Quantification of
Ki-67+ hepatocytes and their distribution along the
central-portal axis. The position index (P.I.) was determined by the
distance to the most adjacent central vein (x), the distance to the most
adjacent portal vein (y), and the distance between the central and portal
veins (z), following the law of cosines. h-j,Two-sided
Kolmogorov-Smirnov tests were performed to analyse the distribution of
Ki-67+ hepatocytes along the central-portal axis.
Histograms (bin-width = 0.1) and shaded curves of the kernel density
estimation with Gaussian approximation were shown. Bars and error-bars:
mean±SEM. No significant differences between
Tert and
Tert livers were found
in uninjured livers (h, n = 4 mice for each group;each
mouse represented by unique dot-shapes;p = 0.58),
in CCl4 injured livers (i, n = 3 mice for
each group; each mouse represented by unique dot-shapes, p
= 0.32), or in DDC injured livers (j, n = 3
mice for each group; each mouse represented by unique
dot-shapes;p = 0.98). Experiments repeated
twice. CV, central vein; PV, portal vein; P.I., position index. Scale bar,
200 μm.
To understand how TERTHigh cells differ from bulk hepatocytes, we
performed RNA-seq on TERTHigh and TERTLow hepatocytes isolated by
FACS from three Tertmice three days after tamoxifen
treatment. RNA-seq showed 3,172 genes differentially expressed between the two
populations (q<0.05, Fig.
2n)(Extended Data Fig. 3j). Gene
ontology (GO) analysis (Fig. 2n) and Database for
Annotation, Visualization and Integrated Discovery (DAVID, Extended Data Fig. 3j) showed that cell cycle genes were upregulated in the
TERTHigh population, while ribosomal genes and mitochondrial genes were
upregulated in the TERTLow population. Gene Set Enrichment Analysis (GSEA)
revealed increased representation of gene sets associated with cell division and
receptor tyrosine kinase activity in the TERTHigh population (Fig. 2o, red), and decreased representation of gene sets
associated with ribosome components, mitochondrial proteins, electron transport chain
genes and hepatocyte metabolic activities (Fig.
2o, grey). Proliferation inTERTHigh hepatocytes was elevated compared
with TERTLow hepatocytes (6.4±1.0% vs.
0.9±0.1%) by 5-ethynyl-2′-deoxyuridine (EdU) incorporation
(7-day drinking water, Extended Data Fig. 6).
Together, these data suggest that TERTHigh hepatocytes are less invested in
the metabolic and synthetic functions of bulk hepatocytes, and more dedicated to
proliferation and homeostatic renewal.
Extended Data Figure 6
EdU incorporation assays
a, Scheme of experiments. b-g, EdU
incorporation in livers of Tert mice treated with
tamoxifen, traced for three days, then treated with EdU in drinking water
for 7 days (1 mg/mL). The overlay image (b), as well as
individual images of HNF4A (c), DAPI (d), EdU
(e) and Tomato (f) were shown. Quantification
of EdU incorporation in hepatocytes (g, n = 5 mice,
each represented by unique dot-colours). Dashed boxes,
EdU+HNF4A+Tomato+
cells. h-k,EdU incorporation in livers of
Tert (h)
and Tert(i) mice
were compared. Co-immunofluorescence for GS (red) and CK19 (white) was
overlaid with EdU (green) and DAPI (blue). Quantification of the
distribution of EdU+ hepatocytes (j,
“pericentral”: in GS+ zones;
“periportal”: 0-2 cell layers adjacent to the portal veins
space or CK19+ bile ducts; “mid-lobular”:
neither “pericentral” nor “periportal”.
Dot-colours represent individual mice) and total EdU+
hepatocytes in Tert and
Tert livers
(k) (n = 5 mice for
Tertlivers, and n
= 4 mice for
Tertlivers). Experiments
repeated twice. Scale bar, 50 μm in d, 200 μm
in i.
To characterize the behaviour of single TERTHigh hepatocytes and their
progeny through clonal analysis and sparse labelling, we injected
Tertmice with a lower dose of tamoxifen
(0.08mg Tam/10g body weight), and traced for 3 days, 3 months and 6 months (Fig. 3a). Confocal microscopy was performed on thick
tissue sections followed by three-dimensional reconstruction (Fig. 3b). The average clone size increased progressively from
single-cells at 3-days, to 2.1±0.2 cells at 3-months, and 4.2±0.4 cells
at 6-months (Fig. 3c). Average clonal density did
not change, indicating no significant loss of TERTHigh hepatocyte clones over
the 6-month trace (Fig. 3d). The irregular shape
of these clones matches the anatomical organization of hepatocytes within hepatic
cords[24]. Co-staining 6-month
trace samples with antibodies to GS revealed that the vast majority of clones resided
outside the GS+ zone (Fig. 3e
and red bars in Fig. 3h), and a subset of these
bordered the GS+ pericentral zone (Fig. 3f and green bars in Fig. 3h). We
also found occasional clones comprised of a mixture of GS+ and
GS- cells (Fig. 3g and blue bars in
Fig. 3h). The “cross-zone”
clones derive from TERTHigh hepatocytes but are comprised of cells with two
distinct zonal fates. These clonal studies matched the findings on homeostatic expansion
of the TERTHigh lineage (Fig. 2), and
further supported the function of TERTHigh hepatocytes as a key source of
hepatocyte renewal.
Figure 3
TERTHigh hepatocytes drive clonal expansion by a self-renewal
mechanism
a-h, 3D analysis of sparse-labelled hepatocyte clones in
Tert;
Rosa26 mice treated with
low-dose tamoxifen, traced for 3 days, 3 months or 6 months. Clone-sizes
(b,c) and clone-number per volume (d) (n =
5, 3, and 4 mice, respectively; each mouse represented by unique dot-colour in
c; cross-bar: mean). Co-IF for Tomato and GS to assess
clone-location in 6-month trace samples (e-h). Quantification of
clone size and position relative to GS+ cells
(h).i-r, Single-molecule RNA FISH on FACS-purified
TERTHigh derived (l-n) and TERTLow
derived (o-q) hepatocytes. Quantification by foci counts
(r, n = 3 mice per time-point, each mouse indicated by
unique dot-shapes. Bars and error-bars are mean+SEM. For cells with
>5 foci, p = 0.56,
p = 2.7e-5,
p = 4.3e-5). Experiments
repeated twice. Scale bars, 50 μm.
TERTHigh hepatocytes could generate clones either by a self-renewal
mechanism, in which the initial cell remains TERTHigh and the progeny are
TERTLow (Fig. 3j), or a simple
duplication mechanism, in which all daughter cells remain TERTHigh (Fig. 3k). To distinguish these mechanisms, we
examined Tert mRNA with single-molecule RNA FISH on sorted
Tomato+ and Tomato- hepatocytes from different tracing
periods (Fig. 3i,l-r), as well as wild-type
hepatocytes (Extended Data Fig. 7). We found that
the percentage of Tomato+ cells with high Tert mRNA
(>5 mRNA foci) was comparable at three days and one month
(80.3±2.0% vs. 75.3±4.8%), but decreased to
18.0±2.2% after one year. Tomato- cells remained
TERTLow, regardless of the tracing periods. The presence of rare cells in
this fraction with high Tert mRNA likely indicates incomplete
recombination with CreERT2. These studies indicate that the
TERTHigh subpopulation both self-renews to replenish the
TERTHigh cells, and differentiates to yield TERTLow daughter
cells.
Extended Data Figure 7
Single-molecule RNA FISH on wild-type hepatocytes
a, Experiment performed on wild-type hepatocytes
isolated by FACS and cytospun. b, Control experimentby omitting
the detection probe for Tert. c,
Quantification by foci counts (n = 3 mice, each represented by
unique dot-shapes. Bars and error-bars are mean+SEM). Experiments
repeated three times. Scale bar, 50 μm.
To understand the ability of TERTHigh hepatocytes to replenish cells
damaged in the pericentral zone, we eliminated pericentral hepatocytes by single-dose
carbon tetrachloride (CCl4) injection[25] (Extended Data Fig. 8c-f).
Although TERTHigh hepatocytes are rare within the GS+
pericentral zone, there was a marked increase in the number of GS+
Tomato+ cells at seven days after injury (Fig. 4a-f). These data indicate that injury to pericentral
hepatocytes activates nearby TERTHigh hepatocytes, and that their progeny
assumes a new zonal identity in healing pericentral wounds. To understand whether
TERTHigh hepatocytes contribute to hepatocyte regeneration after global
injury, we challenged the livers with 0.1%
3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) diet (Fig. 4g and Extended Data Fig. 8g, h).
We found a significant expansion of Tomato+ hepatocytes after one
month DDC-diet (38.0±3.2% vs. 5.6±0.3% in control
livers) (Fig. 4g-j). Some progeny of
TERTHigh cells adopted a ductal fate (Extended Data Fig. 9), consistent with known hepatocyte plasticity in DDC
injury[26]. These findings
reveal that TERTHigh hepatocytes repopulate hepatocytes at an accelerated
rate in the setting of chemical injury.
Extended Data Figure 8
Responses of Tert and
Tertlivers to
injuries
a-b, H&E analysis on uninjured livers.
c-d, H&E analysis on livers 3 days post
CCl4 injection. Artificial white dotted lines encircle the
damage pericentral area. e-f, H&E analysis on livers 7
days post CCl4 injection. g-h, H&E analysis
on livers 1 month post DDC treatment. CV, central vein; PV, portal vein.
Experiments repeated five times. Scale bar, 200 μm.
Figure 4
TERTHigh hepatocytes are critical in liver regeneration
a-f, Single-dose CCl4 liver injury.
Tert;
Rosa26 mice treated with
oil vehicle (b,c) or CCl4
(d,e) analysed by IF for Tomato and GS at day 7
post-treatment. IF Quantification (f); white lines,
GS+ pericentral zone(n = 5 mice).
g-j, DDC diet-induced injury in
Tert;
Rosa26 mice. IF of liver
for Tomato after 30 days treatment with normal diet (h) or DDC diet
(i). IF quantification (j) (n = 4 mice).
k-m, Ablation of TERTHigh hepatocytes via
AAV.lsl.dtA injection to Tert;
Rosa26 mice (n =
4 mice), quantification of Tomato+ cells (m).
n-v, Genetic ablation followed by DDC injury in
Tert;
Rosa26 mice. Livers
analysed by Sirius Red for collagen (o-q), SMA for activated
stellate cells (r-t), and CK19+ cells
(u-w) (n = 4 mice). AAV.GFP injected control animals
(o, r, t) and AAV.lsl. DTA injected
animals (p, s, u).Cross-bars:
mean.Experiments repeated at least twice. Scale bars, 100 μm.
Extended Data Figure 9
Progeny of TERTHigh hepatocytes can adopt ductal fate after
DDC injury
a-d, IF analysis on
Tert livers treated with
tamoxifen and DDC, and traced for 1 month. The overlay image
(a), as well as individual images of Tomato (b),
CK19 (c), and DAPI (d) were shown. e.
Quantification of the percentage of
CK19+Tomato+ cells in all
Tomato+ cells (n = 5 mice,
mean±SEM:10.0±1.2%) f. Quantification
of the percentage of CK19+Tomato+
cells in all CK19+ cells (n = 5 mice,
mean±SEM:6.1±1.0%). Bars: mean. Experiments repeated
three times. Scale bar, 50 μm.
To determine whether TERTHigh hepatocytes are required for normal
injury responses, we ablated Tert-expressing hepatocytes using a
diphtheria toxin (DTA)-based AAV system, in which hepatocyte-specific expression of DTA
is induced upon Cre-mediated deletion of a loxP-EGFP-Stop-loxP
element(Fig. 4k-m). Intravenous
coinfection of wild-type mice with AAV.lsl.DTA together with AAV.Cre resulted in massive
hepatocyte necrosis and death within six days, whereas infection with AAV.lsl.DTA alone
was well tolerated for up to two months and did not induce liver damage (Extended Data Fig. 10f-j). Employing this system in
Tertmice, the abundance of
TERTHigh (Tomato+) cells was reduced by 75.1%
in mice treated with AAV.lsl.DTA compared with AAV.GFP(Fig. 4m). After ablating TERTHigh cells, we induced liver injury
with DDC diet for 30 days (Fig. 4n). Expansion of
the TERTHigh cell lineage (Tomato+) was significantly
suppressed in mice treated with AAV.lsl.DTA compared with those treated with AAV.GFP
(Fig. 4s,v). DDC treatment following
TERTHigh hepatocyte ablation led to a marked increase in liver fibrosis,
evident by an increase in collagen deposition(Fig.
4o-q) and a significant increase in the number of activated stellate cells
(Fig. 4r-t). There was a concomitant increase
in CK19+ cells (Fig. 4u-w),
indicating that with suppression of hepatocyte renewal the ductal reaction
characteristic of DDC treatment is enhanced. Finally, we replicated these results using
an independently constructed AAV that allows induction of DTA through Cre-mediated
inversion and deletion steps (AAV.flex.DTA) (Extended
Data Fig. 10). Taken together, these data show that TERTHigh
hepatocytes are critical for normal liver regeneration in the setting of DDC injury and
that regeneration in their absence results in elevated stellate cell activation and
fibrosis.
Extended Data Figure 10
Characterization of AAV.lsl.DTA and AAV.flex.DTA
a-d, Epifluorescence of EGFP, as well as DAPI staining
from livers 4 days after injection with AAV.GFP (a),
AAV.lsl.DTA (b), AAV.flex.DTA (c), and uninjected
control (d) shown. e, Diagram of AAV.flex.DTA, and
recombination events that lead to DTA expression. f, Survival
effects of AAV.TBG viruses. Combined injection of
“AAV.lsl.DTA+AAV.Cre” (red line) or
“AAV.flex.DTA+AAV.Cre” (green line) lead to a narrow
window of complete mortality between 4.5-6 days; in contrast,
“AAV.GFP+AAV.Cre”, AAV.lsl.DTA, or AAV.flex.DTA
injection did not result in mortality. Between 4-6 mice were used for each
regimen. Survived mice were monitored for up to 2 months.
g-j,H&E on liver sections from mice injected with
AAV.lsl.DTA alone (g), AAV.flex.DTA alone (h),
“AAV.lsl.DTA+AAV.Cre” (i), and
“AAV.flex.DTA+AAV.Cre” (j).
k-r, Livers injected with AAV.flex.DTA and Tamoxifen showed
reduction of TERTHigh cells (k, l), as well as
increases in collagen deposit (m, n), activated stellate cells
(o, p) and ductal cells (q, r). Experiments
repeated three times for a-d, and twice for g-j,
k-r. Scale bars, 200 μm.
Based on the dispersed location of TERTHigh hepatocytes and their
clonal behaviour during regeneration, we propose a ‘distributed model’
to explain hepatocyte renewal. According to this ‘distributed model’,
rare TERTHigh hepatocytes located throughout the lobule form enlarging clones
during homeostasis in response to hepatocyte loss and this response is accelerated
during liver injury (Fig. 5). These findings
provide a framework to explain several longstanding observations in hepatocyte renewal
including: the ability of the liver to recover from injuries in any lobular zone; a
general lack of evidence for long-range migration of hepatocytes; and the presence of
rare proliferating hepatocytes throughout the lobule. Our RNA-seq data suggest that
repopulating activity and metabolism may be segregated within the hepatocyte population.
Telomerase activity is critical for preserving long-term cell division and chromosomal
stability. Maintaining the liver using a subset of hepatocytes with elevated telomerase
and reduced metabolic activity may be important for long-term tissue maintenance, for
preventing the accrual of damaged DNA caused by reactive oxygen species and for
suppressing hepatocellular carcinoma. We speculate that depletion or dysfunction of an
analogous subset of repopulating hepatocytes in humans may underlie the pathophysiology
of cirrhosis. Strategies to mitigate this cellular depletion may prove useful in
treating cirrhosis of diverse etiologies.
Figure 5
A distributed modelto explain hepatocyte renewal
a, TERTHigh hepatocytes generate expanding clones
comprised of both TERTHigh and TERTLow hepatocytes.
b, Rare TERTHigh hepatocytes distributed throughout
the lobule form enlarging clones during homeostasis in response to local
hepatocyte loss. c, Repopulation of injured liver by clonal
expansion ofTERTHigh hepatocytes is accelerated during injury. Blue
vessels, portal and central veins; pink vessel, hepatic artery; small green
cells, cholangiocytes; large green cells, pericentral hepatocytes; red cells,
TERTHigh hepatocytes; black cells, damaged hepatocytes.
Methods
Generation of the Tert knock-in
line
The targeting vector was generated by serial recombineering and gate-way
cloning. Homology arms (mm10 chr13: 73,621,344 - 73,631,102) were cloned from
the BAC (RP24-342O18) via recombineering. A codon-optimized intron-CreERT2-NeoR
cassette[27] was
inserted in the endogenous translational start site of Tert
(mm10 chr13: 73,627,032 – 73,627,033) via recombineering. The final
targeting vector was created via gate-way cloning to the pWS-TK2 vector with
thymidine kinase cassettes at both ends of the homology arms, as previously
described[28]. The
targeting vector was linearized and electroporated into JM8/F6 mouse ES cells.
Correctly targeted ES clones were selected by southern blots and karyotypes, and
then injected into BALB/c blastocysts to generate the knock-in line.
Tertmice were born at
normal Mendelian frequency. To verify the efficacy of CreERT2 in the ES, the
Tert clone was targeted
with a modified “Rosa26-mTmG” targeting vector[29] using HygroR as the selection
gene. The double knock-in cells were treated with 500 nM 4-hydroxy tamoxifen
(4-OHT) to evaluate recombination efficiency.
AAV production
All AAVs used in this study were produced with
cis-plasmids containing the full TBG promoter [two
copies of the α-1-microglobulin/bikunin precursor
(AMBP) enhancer elements followed by the promoter of the
SERPINA7 gene and a mini-intron], an AAV8 serotype
packaging plasmid, and an adenovirus helper plasmid. AAV.GFP
(AAV8.TBG.PI.eGFP.WPRE.bGH, catalog #: AV-8-PV0146) and AAV.Cre
(AAV8.TBG.PI.Cre.rBG, catalog #AV-8-PV1091) were purchased from
University of Pennsylvania Vector Core. AAV.lsl.dtA contains a strong SV40 stop
element cloned from the Lox-Stop-Lox TOPO plasmid[30] (addgene Plasmid #11584).
AAV.flex.dtA was modified from pAAV-mCherry-flex-dtA[31] (addgene Plasmid #58536) with
the following changes: the EF-1α promoter was swapped with the TBG
promoter, and mCherry was swapped with EGFP. HEK293T cells were transfected and
grown on Corning multi-layer flasks to produce the viruses. The viruses were
purified by Iodixanol (Sigma-Aldrich) gradient ultracentrifugation[32], and tittered by
qPCR[33] and SYPRO Ruby
(ThermoFisher) protein gel staining with standards.
Animals
Tertmice were bred with
the Rosa26 reporter
(Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J)[34] to generate
Tertmice for analysis.
Two-month old mice were intraperitoneally injected with tamoxifen (Caymon, 1
mg/10 g weight) dissolved in 100 μL sesameoil (Sigma-Aldrich).
Sparse-labelling was achieved by injecting tamoxifen at 0.08 mg/10 g weight. EdU
(Carbosynth) was administrated via drinking water (1 mg/mL) daily for seven
days. AAV was diluted to 4e11 genome particles in 100 μL normal saline
(per mouse), and injected intravenously. For DDC injury, mice received diet
TD.07571 (Harlan) containing 0.1% DDC (Sigma-Aldrich) ad
libitum. For CCl4 injury, mice were injected with liquid
CCl4 (Sigma-Aldrich, 10 μL/10 g weight) dissolved in
sesameoil (Sigma-Aldrich).
Statistics
When comparing two groups, p values were determined by
the two-sided unpaired t-test. When comparing more than two
groups, p values were determined by the one-way ANOVA with
Tukey's HSD test performed as the post hoc analysis.
Data significance were also tested by non-parametric statistics using two-sided
unpaired Wilcoxon–Mann–Whitney test for two-group comparison,
and Kruskal–Wallis one-way ANOVA on ranks with Conover–Iman test
performed as the post hoc analysis for more than two groups.
Kolmogorov-Smirnov test was performed to compare the distribution patterns of
continuous variables. The animals were randomly assigned to each
experimental/control group. The investigators were not blinded to allocation
during experiments and outcome assessment. Data are presented as
“mean±SEM” in the text. Graphs were generated by the
ggplot2 package[35] in R.
FACS Experiments
Cells were isolated by standard two-step collagenase perfusion. Liver
perfusion medium (Life Technologies) and filtered (0.22 μm) liver digest
medium (Life Technologies) were perfused via the portal vein sequentially,
according to the manufacturer's instructions. Dissociated liver was
passed through a 100μm cell strainer and the hepatocytes were enriched
by low-speed centrifugation (50xg for 3 min) for three times in
hepatocyte wash medium (Life Technologies). Cells were analysed and/or sorted
with a BD Aria II flow cytometer using a 100 μm nozzle. Dead cells were
excluded based on Topro3 (1 μM) or DAPI (1 μM) (Life
Technologies) incorporation. For ploidy analysis, hepatocytes were incubated in
Hoechst33342 (15 μg/ml) and Reserpine (5 μM) at 37 degrees for
30min before analysis.
Immunofluorescence (IF), Imunohistochemistry (IHC), EdU detection,
single-molecule RNA FISH and SiriusRed staining
Livers were cut into small blocks, and fixed in zinc-buffered formalin
(Anatech). For IF, tissue blocks were fixed overnight at 4 degrees,
cryoprotected in 30% (w/v) sucrose, embedded in OCT, snap-frozen and cut
into 7 μm cryosections. For thick tissue analysis, tissue blocks were
briefly fixed, embedded in low-melting agarose and cut into 300 μm
sections using a vibratome, as previously described[36]. For IHC, tissue blocks were fixed
overnight at 4 degrees, incubated in 70% ethanol overnight, embedded in
paraffin and cut into 5 μm sections. Antigen retrieval was performed
with citrate (pH 6) buffer (Biogenex) for 10 min using a pressure cooker. Slides
were stained with primary and secondary antibodies in blocking buffer
(1% BSA, 5% donkey serum, 0.25% Triton-X in PBS)
overnight at 4 degrees, incubated with 1mM DAPI for 5min at room temperature,
and mounted in Aqua poly/mount (Polysciences), or Vectashield with DAPI (Vector
laboratories). DAB Peroxidase Substrate Kit (Vector Laboratories) or Emerald
chromogen kit (Abcam) were used for IHC. EdU incorporation was detected by using
the Click-iTEdU Alexa Fluor 488 Imaging Kit (Life Technologies). For analysis on
cytospun samples, cells were FACS-sorted and cytospun (500 rpm/28
g for 5min) onto slides. Slides were fixed in 4%
(v/v) PFA for 5min, and stained with primary and secondary antibodies in
blocking buffer for 1hour at room temperature, and then mounted in Prolong Gold
with DAPI mounting medium (Life Technologies). Alternatively, slides were fixed
in 4% (v/v) PFA for 20min, and proceeded for single-molecule RNA FISH
using an RNAscope® 2.0 HD Detection-RED kit (ACDbio) according to the
manufacturer's instruction. SiriusRed staining for collagen deposit was
performed with Fast Green as the counter-stain, using a staining kit (Chondrex),
according to the manufacturer's instruction.
qPCR and RNAseq
RT-qPCR and RNA-seq were performed on TERTHigh and
TERTLow hepatocytes isolated by FACS from three
Tertmice three days after
tamoxifen treatment. Hepatocytes were sorted directly in TRIzol-LS (Life
Technologies). Total RNA was extracted and purified using an RNeasy micro kit
(Qiagen) according to the manufacturers’ instructions. qPCR was
performed using the following primers: Tert (pair1)[37] CCACGTATGTGTCCATCAGC /
TAGAGGATTGCCACTGGCTC; Tert (pair2) ATCTGCAGGATTCAGATGCC /
GCAGGAAGTGCAGGAAGAAG; Tert (pair3)[21]TGGCTTGCTGCTGGACACTC /
TGAGGCTCGTCTTAATTGAGGTCTG; Gtf2b CTCTGTGGCGGCAGCAGCTATTT /
CGAGGGTAGATCAGTCTGTAGGA. qPCR reactions were carried out using Brilliant II
SYBR® Green master mix (Strategene) and Roche lightcycler 480. Cq values
were determined by the second derivative maximum method, and fold-changes were
calculated by 2-ΔCq. RNAseq libraries were constructed using
a KAPA Stranded mRNA-Seq Kit (Kapa). Libraries were sequenced on the Illumina
NextSeq platform, generating 55∼75 million 75bp paired-end reads per
library. Three biological replicates per sample were analysed. Raw reads were
trimmed by TrimGalore0.4.0 (Babraham Bioinformatics), mapped to mm10 by tophat
2.0.13[38], analysed by
the DEseq2 packages[39]. The
RNA-seq data have been deposited in NCBI's Gene Expression Omnibus and
are accessible through GEO Series accession number GSE104415.
Imaging Analysis
Fluorescent images were analysed by Leica LAS AF, ImageJ, Adobe
Photoshop and Fluorender. Area Index was defined by the liver area covered by
Tomato+ cells as the percentage of total area, and
quantified by ImageJ. 3D reconstruction was performed using Fluorender.
Multicellular clones were imaged in 258 × 258 × 100
μm3 volumes by a Leica SP8 confocal microscope, or a
Prairie Ultima IV two-photon microscope. Clones composed of more than eight
cells often extended the imaging volume, and therefore were counted as eight
cells. The surface planar view was created by maximum-projection of the first 12
μm volume close to the surfaceto approximate staining results from thin
sections. For co-immunostaining with GS, 580 × 580 × 100
μm3 volumes were imaged. Stitched single-plane images
were processed from individual tiles by Adobe Photoshop. Number of
EdU+, Ki67+, GS+,
CK19+ hepatocytes were manually counted.
TRAP assays
Telomere Repeat Amplification Protocol (TRAP) was carried out by a
previously established protocol[40]. FACS-sorted cells or homogenized tissue were lysed in NP40
buffer (25 mM HEPES-KOH, 400 mM NaCl, 1.5 mM MgCl2, 10%
glycerol, 0.5% NP40, and 1 mM DTT [pH 7.5] supplemented
with protease inhibitors).
Ethical Compliance
All animal protocols were approved by the Institutional Animal Care and
Use Committee at Stanford University. All experiments have complied with
relevant ethical regulations by Stanford University.
Code availability
Codes are available from the corresponding author upon request.
Data availability
The source data for the RNA-seq study are available in the GEO
repository under accession numbers GSE104415.
Generation and characterization of the
Tert knock-in
line
a-d, Tert targeting
strategy and southern-blot strategy (a). Southern-blots using a
5′probe (b), a NeoR probe (c), and a
3′probe (d). KI, knock-in cells. WT, wild-type cells.
For gel source data, see Supplementary Figure 1. e-g,
Tertmouse embryonic stem cells showed either membrane Tomato (f,
overlaid on bright-field image), or membrane EGFP(g, overlaid
on bright-field image) in response to 500nM 4-hydroxy tamoxifen (4-HT).
h, hepatocytes from
Tert;
Rosa26 livers before
and after FACS-enrichment. i, Tamoxifen dose response of
Tert livers (n = 3
mice for each group, cross-bar: mean). j, Quantification of the
TRAP assay shown in Fig.1e by
densitometry. k-n, Co-immunofluorescence for Tomato (red) and
CD45 (k, blood cells, 202 cells examined), CD68
(l, Kupffer cells, 179 cells examined), GFAP (m,
stellate cells, 158 cells examined) and PECAM (n, endothelial,
167 cells examined) (each in green) in
Tert;
Rosa26 liver, 3-day
trace, with DAPI (blue). Experiments repeated twice for b-d,
f-g, k-n. Scale bars, 100 μm in
g,h, 50 μm in k-n.
Ploidy and nuclear profiles of the TERTLow and
TERTHigh lineages
a-c, Ploidy analysis by Hoechst incorporation and FACS
in TERTLow (a) and TERTHigh
(b) hepatocytes. Quantification showed no significant
differences between TERTLow and TERTHighcells
regarding ploidies (c, n = 5 mice, each represented by
unique dot-shapes). d-f, Nuclei count by Tomato(red),
phalloidin(green) and DAPI(blue) in livers traced by 3 days (d)
and 6 months (e). Quantification showed no significant
differences between TERTLow and TERTHighcells in
binuclei fractions (f, n = 4 mice for each group, each
represented by unique dot-shapes). Experiments repeated twice. Scale bar, 50
μm.
Characterization of the lineage expansion of TERTHigh
hepatocytes
a-e, IF performed on
Tert;
Rosa26 livers after
one-year trace showed TERTHigh hepatocytes exclusively gave rise
to hepatocytes. f-i, Repeated injections showed
TERTHigh cells as a constant proportion of the liver. Lineage
expansion over one injection (g) and three injections
(h) was quantified (i, n = 3 mice for
each group; cross-bar: mean). j, Heat map showing
differentially regulated genes among all TERTLow and
TERTHigh samples. Class I and Class 2 refer to genes
significantly down-regulated and up-regulated in TERTHigh
samples, respectively. Genes assigned to DAVID- generated annotation
clusters shown on the right. Experiments repeated twice. Scale bar, 200
μm.
Zonal pattern of TERTHigh lineage hepatocytes
a-d, Stitched images of IF for Tomato protein (red) and
GS (green) in liver sections from Tertmice treated with
tamoxifen and traced for three days (a), three months
(b), six months (c) or one year
(d). e-g, FACS-isolated and
cytospunhepatocytes from Tertmice treated with
tamoxifen and traced for three days were stained for CPS1 (red) and GS
(green) in TERTLow (e) and TERTHigh
hepatocytes (f), and quantified for the GS+
fraction of all cells (g, n = 3 mice; cross-bars:
mean). Experiments repeated three times. Scale bars, 200 μm.
Distribution of proliferating hepatocytes in
Tert and
Tert livers in
homeostasis and under injury hepatocytes
a-f, Livers were stained with anti-Ki-67 antibody with
standard immunohistochemistry. Ki-67+ nuclei were
indicated by brown colours in uninjured livers (a,
b), and CCl4 (10 μL/10 g weight) injured
livers (c, d), with haematoxylin counterstain in
light blue. Green chromogen was used to indicate Ki-67+
nuclei in DDC (0.1%) treated livers (e,
f). Hepatocyte nuclei were distinguished by size and
morphology. Examples of Ki-67+ hepatocytes nuclei were
shown in box insets. g, Quantification of
Ki-67+ hepatocytes and their distribution along the
central-portal axis. The position index (P.I.) was determined by the
distance to the most adjacent central vein (x), the distance to the most
adjacent portal vein (y), and the distance between the central and portal
veins (z), following the law of cosines. h-j,Two-sided
Kolmogorov-Smirnov tests were performed to analyse the distribution of
Ki-67+ hepatocytes along the central-portal axis.
Histograms (bin-width = 0.1) and shaded curves of the kernel density
estimation with Gaussian approximation were shown. Bars and error-bars:
mean±SEM. No significant differences between
Tert and
Tert livers were found
in uninjured livers (h, n = 4 mice for each group;each
mouse represented by unique dot-shapes;p = 0.58),
in CCl4 injured livers (i, n = 3 mice for
each group; each mouse represented by unique dot-shapes, p
= 0.32), or in DDC injured livers (j, n = 3
mice for each group; each mouse represented by unique
dot-shapes;p = 0.98). Experiments repeated
twice. CV, central vein; PV, portal vein; P.I., position index. Scale bar,
200 μm.
EdU incorporation assays
a, Scheme of experiments. b-g, EdU
incorporation in livers of Tertmice treated with
tamoxifen, traced for three days, then treated with EdU in drinking water
for 7 days (1 mg/mL). The overlay image (b), as well as
individual images of HNF4A (c), DAPI (d), EdU
(e) and Tomato (f) were shown. Quantification
of EdU incorporation in hepatocytes (g, n = 5 mice,
each represented by unique dot-colours). Dashed boxes,
EdU+HNF4A+Tomato+
cells. h-k,EdU incorporation in livers of
Tert (h)
and Tert(i) mice
were compared. Co-immunofluorescence for GS (red) and CK19 (white) was
overlaid with EdU (green) and DAPI (blue). Quantification of the
distribution of EdU+ hepatocytes (j,
“pericentral”: in GS+ zones;
“periportal”: 0-2 cell layers adjacent to the portal veins
space or CK19+ bile ducts; “mid-lobular”:
neither “pericentral” nor “periportal”.
Dot-colours represent individual mice) and total EdU+
hepatocytes in Tert and
Tert livers
(k) (n = 5 mice for
Tertlivers, and n
= 4 mice for
Tertlivers). Experiments
repeated twice. Scale bar, 50 μm in d, 200 μm
in i.
Single-molecule RNA FISH on wild-type hepatocytes
a, Experiment performed on wild-type hepatocytes
isolated by FACS and cytospun. b, Control experimentby omitting
the detection probe for Tert. c,
Quantification by foci counts (n = 3 mice, each represented by
unique dot-shapes. Bars and error-bars are mean+SEM). Experiments
repeated three times. Scale bar, 50 μm.
Responses of Tert and
Tertlivers to
injuries
a-b, H&E analysis on uninjured livers.
c-d, H&E analysis on livers 3 days post
CCl4 injection. Artificial white dotted lines encircle the
damage pericentral area. e-f, H&E analysis on livers 7
days post CCl4 injection. g-h, H&E analysis
on livers 1 month post DDC treatment. CV, central vein; PV, portal vein.
Experiments repeated five times. Scale bar, 200 μm.
Progeny of TERTHigh hepatocytes can adopt ductal fate after
DDC injury
a-d, IF analysis on
Tert livers treated with
tamoxifen and DDC, and traced for 1 month. The overlay image
(a), as well as individual images of Tomato (b),
CK19 (c), and DAPI (d) were shown. e.
Quantification of the percentage of
CK19+Tomato+ cells in all
Tomato+ cells (n = 5 mice,
mean±SEM:10.0±1.2%) f. Quantification
of the percentage of CK19+Tomato+
cells in all CK19+ cells (n = 5 mice,
mean±SEM:6.1±1.0%). Bars: mean. Experiments repeated
three times. Scale bar, 50 μm.
Characterization of AAV.lsl.DTA and AAV.flex.DTA
a-d, Epifluorescence of EGFP, as well as DAPI staining
from livers 4 days after injection with AAV.GFP (a),
AAV.lsl.DTA (b), AAV.flex.DTA (c), and uninjected
control (d) shown. e, Diagram of AAV.flex.DTA, and
recombination events that lead to DTA expression. f, Survival
effects of AAV.TBG viruses. Combined injection of
“AAV.lsl.DTA+AAV.Cre” (red line) or
“AAV.flex.DTA+AAV.Cre” (green line) lead to a narrow
window of complete mortality between 4.5-6 days; in contrast,
“AAV.GFP+AAV.Cre”, AAV.lsl.DTA, or AAV.flex.DTA
injection did not result in mortality. Between 4-6 mice were used for each
regimen. Survived mice were monitored for up to 2 months.
g-j,H&E on liver sections from mice injected with
AAV.lsl.DTA alone (g), AAV.flex.DTA alone (h),
“AAV.lsl.DTA+AAV.Cre” (i), and
“AAV.flex.DTA+AAV.Cre” (j).
k-r, Livers injected with AAV.flex.DTA and Tamoxifen showed
reduction of TERTHigh cells (k, l), as well as
increases in collagen deposit (m, n), activated stellate cells
(o, p) and ductal cells (q, r). Experiments
repeated three times for a-d, and twice for g-j,
k-r. Scale bars, 200 μm.
Authors: E L Jackson; N Willis; K Mercer; R T Bronson; D Crowley; R Montoya; T Jacks; D A Tuveson Journal: Genes Dev Date: 2001-12-15 Impact factor: 11.361
Authors: Hugo J Snippert; Arnout G Schepers; Gabriele Delconte; Peter D Siersema; Hans Clevers Journal: Nat Protoc Date: 2011-07-28 Impact factor: 13.491
Authors: Chow Hiang Ang; Shih Han Hsu; Fusheng Guo; Chong Teik Tan; Victor C Yu; Jane E Visvader; Pierce K H Chow; Nai Yang Fu Journal: Proc Natl Acad Sci U S A Date: 2019-09-05 Impact factor: 11.205
Authors: Nicola Ferreira; Kara L Perks; Giulia Rossetti; Danielle L Rudler; Laetitia A Hughes; Judith A Ermer; Louis H Scott; Irina Kuznetsova; Tara R Richman; Vinod K Narayana; Laila N Abudulai; Anne-Marie J Shearwood; Henrietta Cserne Szappanos; Dedreia Tull; George C Yeoh; Livia C Hool; Aleksandra Filipovska; Oliver Rackham Journal: EMBO J Date: 2019-11-13 Impact factor: 11.598